abstract |
The present disclosure provides compositions (e.g., antibodies and formulations) and methods for targeting a coronavirus (e.g., SARS-CoV-2). Such antibodies may be incorporated into formulations and/or pharmaceutical compositions, for example for the treatment for or protection against diseases that may be caused by a coronavirus, such as COVID-19. |